Last reviewed · How we verify
NCT03328429
Comparison of Intraoperative and Postoperative Outcomes of Bartholin Gland Marsupialisation Versus Cystectomy
NA trial testing Excision in Bartholin Abscess in 154 participants. Completed in 1 May 2018.
15 December 2017
Quick facts
| Lead sponsor | Kanuni Sultan Suleyman Training and Research Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 154 |
| Start date | 1 January 2017 |
| Primary completion | 15 December 2017 |
| Estimated completion | 1 May 2018 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Excision
- Marsupialization
Conditions studied
- Bartholin Abscess — all drugs for Bartholin Abscess →
Sponsor
Kanuni Sultan Suleyman Training and Research Hospital
Who can join
Adults 18 to 40, female only, with Bartholin Abscess. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To compare intraoperative and postoperative outcomes of Bartholin marsupialisation versus excision
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03328429
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Excision
Trials testing the same drug.
- NCT07281430 — Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04) · NA · recruiting
- NCT06673095 — Narrow Excision Versus Wide Excision for the Treatment of Adults With Invasive Cutaneous Melanoma, ICEMAN Trial · NA · recruiting
- NCT06611553 — Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S02) · NA · active not recruiting
- NCT06611540 — Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S03) · NA · active not recruiting
- NCT06498661 — Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01) · NA · recruiting
Other Kanuni Sultan Suleyman Training and Research Hospital trials
Trials by the same sponsor.
- NCT07519551 — Serum Myostatin and Irisin Levels in Postmenopausal Women: Association With Bone Mineral Density and Muscle Strength · not yet recruiting
- NCT07480330 — Serum Neurofilament Light Chain Levels and Neuropathy Severity in Diabetic Polyneuropathy · not yet recruiting
- NCT07425405 — Daily Screen Exposure and Preoperative Anxiety in Children Aged 2-5 Years · recruiting
- NCT07358754 — The Relationship Between Serum S100B and Brain-Derived Neurotrophic Factor · recruiting
- NCT07261436 — Performance Comparison of Large Language Models in TAP Block Ultrasound Interpretation · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03328429 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kanuni Sultan Suleyman Training and Research Hospital
- Last refreshed: 27 June 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03328429.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing